APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,431,718 | +57.5% | 1,115,450 | +277.2% | 0.65% | +36.9% |
| Q2 2023 | $26,940,456 | -50.3% | 295,724 | -64.0% | 0.48% | -54.4% |
| Q1 2023 | $54,153,160 | +758.4% | 821,000 | +573.0% | 1.05% | +968.4% |
| Q4 2022 | $6,308,620 | +42.1% | 122,000 | +87.7% | 0.10% | +60.7% |
| Q3 2022 | $4,439,000 | -87.8% | 65,000 | -90.9% | 0.06% | -86.0% |
| Q1 2022 | $36,278,000 | +63.3% | 714,000 | +51.9% | 0.44% | +74.4% |
| Q4 2021 | $22,220,000 | -40.2% | 470,000 | -58.3% | 0.25% | -41.2% |
| Q3 2021 | $37,167,000 | +33.5% | 1,127,643 | +156.0% | 0.42% | +16.8% |
| Q2 2021 | $27,839,000 | +1147.8% | 440,500 | +747.1% | 0.36% | +658.3% |
| Q1 2021 | $2,231,000 | +23.4% | 52,000 | -13.3% | 0.05% | +14.3% |
| Q3 2020 | $1,808,000 | +1155.6% | 60,000 | +1011.1% | 0.04% | +425.0% |
| Q1 2020 | $144,000 | -95.5% | 5,400 | -94.9% | 0.01% | -92.6% |
| Q4 2019 | $3,227,000 | – | 105,400 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |